SCHEMBL6134311

SCHEMBL6134311

CCCNC(=O)c1nc(-c2ccccc2)c(-c2ccc(=O)n(C(C)C)n2)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.41
KDM4E B2RXH2 3/20 0.41
GAA P10253 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
DGAT1 O75907 1/20 0.38
POLB P06746 3/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 2/20 0.38
BRD4 O60885 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ADORA2A P29274 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
ESR1 P03372 1/20 0.36
JMJD7 P0C870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133793 0.94 HSD17B10 (0.46) KDM4EMEN1KMT2ADGAT1HSD17B10
SCHEMBL6133811 0.92 NPC1 (0.40) HPGDKDM4EALDH1A1DGAT1POLB
SCHEMBL6133465 0.91 HSD17B10 (0.39) KDM4EGAAALDH1A1MEN1KMT2A
SCHEMBL6134990 0.90 MAPT (0.42) ALDH1A1MEN1KMT2ADGAT1POLB
SCHEMBL6135410 0.90 RAB9A (0.44) HPGDKDM4EALDH1A1MEN1KMT2A
SCHEMBL6133569 0.90 HDAC6 (0.45) KDM4EGAAALDH1A1MEN1KMT2A
SCHEMBL6924703 0.90 CAMK2D (0.42) HPGDKDM4EKMT2APOLBHSD17B10
SCHEMBL6133161 0.88 L3MBTL1 (0.47) ALDH1A1MEN1KMT2APOLBHSD17B10
SCHEMBL6134295 0.87 TP53 (0.37) KDM4EALDH1A1POLBHSD17B10TP53
SCHEMBL6133513 0.87 ALDH1A1 (0.46) HPGDKDM4EGAAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed
EP-1441732-A2 THIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-04 EP disclosed
WO-2003039451-A2 THIAZOLE PYRIDAZINONES AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR HPGD 1177/4885KDM4E 3814/4885GAA 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.